Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 113749733 | 11374973 | 3 | F | 2014 | 20160822 | 20150813 | 20160906 | EXP | IT-ASTRAZENECA-2014SE45527 | ASTRAZENECA | 65.00 | YR | F | Y | 0.00000 | 20160906 | OT | IT | IT |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 113749733 | 11374973 | 1 | PS | ARIMIDEX | ANASTROZOLE | 1 | Oral | 20541 | 1 | MG | TABLET | QD | |||||||
| 113749733 | 11374973 | 2 | SS | ARIMIDEX | ANASTROZOLE | 1 | Oral | 20541 | 25 | MG | TABLET | QD | |||||||
| 113749733 | 11374973 | 3 | C | RANIBEN | 2 | 300.0MG UNKNOWN | 0 | 300 | MG | ||||||||||
| 113749733 | 11374973 | 4 | C | RANIBEN | 2 | 300.0MG UNKNOWN | 0 | 300 | MG | ||||||||||
| 113749733 | 11374973 | 5 | C | DRUGS USED IN CHEMOTHERAPY | 2 | 0 | |||||||||||||
| 113749733 | 11374973 | 6 | C | VITAMIN C | ASCORBIC ACID | 1 | 0 | SOLUTION FOR INJECTION | |||||||||||
| 113749733 | 11374973 | 7 | C | ANTINEOPLASTIC AGENTS | UNSPECIFIED INGREDIENT | 1 | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 113749733 | 11374973 | 1 | Breast cancer |
| 113749733 | 11374973 | 2 | Breast cancer |
| 113749733 | 11374973 | 3 | Gastrooesophageal reflux disease |
| 113749733 | 11374973 | 4 | Gastrooesophageal reflux disease |
| 113749733 | 11374973 | 5 | Chemotherapy |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 113749733 | 11374973 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 113749733 | 11374973 | Asthenia | |
| 113749733 | 11374973 | Balance disorder | |
| 113749733 | 11374973 | Bone formation increased | |
| 113749733 | 11374973 | Breast haemorrhage | |
| 113749733 | 11374973 | Cataract | |
| 113749733 | 11374973 | Chronic gastritis | |
| 113749733 | 11374973 | Circumstance or information capable of leading to medication error | |
| 113749733 | 11374973 | Confusional state | |
| 113749733 | 11374973 | Eye disorder | |
| 113749733 | 11374973 | Gallbladder polyp | |
| 113749733 | 11374973 | Hair colour changes | |
| 113749733 | 11374973 | Helicobacter infection | |
| 113749733 | 11374973 | Hormone level abnormal | |
| 113749733 | 11374973 | Hypoaesthesia | |
| 113749733 | 11374973 | Trigger finger | |
| 113749733 | 11374973 | Vitreous detachment | |
| 113749733 | 11374973 | Weight decreased |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 113749733 | 11374973 | 1 | 201404 | 0 | ||
| 113749733 | 11374973 | 2 | 201404 | 0 | ||
| 113749733 | 11374973 | 4 | 1970 | 0 |